Research Mate Inc

1. Bausch Health US, LLC $416,482 176 payments
2. Lexicon Pharmaceuticals, Inc. $74,675 17 payments
3. Takeda Pharmaceuticals U.S.A., Inc. $28,802 2 payments
4. Chiesi USA, Inc. $22,750 1 payment

1. Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) $416,482 176 payments
2. Lx9211.1-204-Dpn $56,936 10 payments
3. A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001) $28,802 2 payments
4. A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp 500g) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) (PILLAR) $22,750 1 payment
5. Lx9211 $17,740 7 payments

1. Patient care $56,623 10 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.